Senior Scientist
Aetion, Inc
Brenna Kirk, an accomplished Senior Scientist at Aetion, stands at the forefront of pharmacoepidemiology. With a profound commitment to unraveling the intricacies of real-world evidence, Brenna's expertise shines through her recent endeavors, which have centered on critical aspects of our time.
In the rapidly evolving landscape of healthcare, Brenna has emerged as a driving force in the realm of COVID-19 vaccine safety and efficacy. Her work not only contributes to the collective understanding of these paramount concerns but also paves the way for informed decision-making on a global scale. Her insights offer invaluable perspectives that resonate across medical and scientific communities.
Brenna's academic journey led her to the prestigious Harvard T.H. Chan School of Public Health, where she earned a Master of Science in Epidemiology in 2019. This formative experience provided her with a solid foundation, empowering her to address complex epidemiological questions with rigor and innovation. With a passion for research that translates into real-world impact, Brenna Kirk continues to inspire her peers and collaborators. Her unwavering dedication to advancing pharmacoepidemiology is an asset to Aetion and the entire field.
